Literature DB >> 8434642

Role of platelet-activating factor in polymorphonuclear neutrophil recruitment in reperfused ischemic rabbit heart.

G Montrucchio1, G Alloatti, F Mariano, A Comino, G Cacace, R Polloni, P G De Filippi, G Emanuelli, G Camussi.   

Abstract

This study investigated the role of platelet-activating factor in the recruitment of polymorphonuclear neutrophils (PMN) in a rabbit model of cardiac ischemia and reperfusion. The accumulation of PMN was evaluated 2 and 24 hours after removal of 40 minutes of coronary occlusion by morphometric analysis and 111In-labeled PMN infiltration. The administration of two structurally unrelated platelet-activating factor-receptor antagonists (SDZ 63-675, 5 mg/kg body weight, and WEB 2170, 5 mg/kg body weight) before reperfusion significantly reduced the accumulation of PMN, as well as the hemodynamic alterations and the size of necrotic area. Two hours after reperfusion, the percentage of increase of 111In-labeled PMN in transmural central ischemic zone was significantly reduced in rabbits pretreated with SDZ 63-675 (51.4 +/- 7.9) or WEB 2170 (32.4 +/- 8.8) with respect to untreated rabbits (107.6 +/- 13.5). The morphometric analysis of myocardial sections confirmed the reduction of PMN infiltration at 2 hours and demonstrated that at 24 hours the phenomenon was even more significant. In addition, SDZ 63-675 and WEB 2170 prevented early transient bradycardia and hypotension and reduced the infarct size, judged by staining with tetrazolium at 2 and 24 hours after reperfusion, and by histological examination at 24 hours. These results suggest that platelet-activating factor is involved in the accumulation of PMN in the reperfused ischemic myocardium and contributes to the evolution of myocardial injury.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8434642      PMCID: PMC1886743     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  36 in total

Review 1.  The role of platelet-activating factor in inflammation.

Authors:  G Camussi; C Tetta; C Baglioni
Journal:  Clin Immunol Immunopathol       Date:  1990-12

Review 2.  The role of platelet-activating factor in endothelial cells.

Authors:  S M Prescott; T M McIntyre; G A Zimmerman
Journal:  Thromb Haemost       Date:  1990-08-13       Impact factor: 5.249

3.  Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.

Authors:  H O Heuer; J Casals-Stenzel; G Muacevic; K H Weber
Journal:  J Pharmacol Exp Ther       Date:  1990-12       Impact factor: 4.030

4.  Role of platelet-activating factor in the reperfusion injury of rabbit ischemic heart.

Authors:  G Montrucchio; G Alloatti; F Mariano; R de Paulis; A Comino; G Emanuelli; G Camussi
Journal:  Am J Pathol       Date:  1990-07       Impact factor: 4.307

Review 5.  Endothelial, platelet and leukocyte interactions in ischemic heart disease: insights into potential mechanisms and their clinical relevance.

Authors:  J L Dinerman; J L Mehta
Journal:  J Am Coll Cardiol       Date:  1990-07       Impact factor: 24.094

6.  Platelet-activating factor (PAF) induces platelet/neutrophil co-operation during myocardial reperfusion.

Authors:  G Alloatti; G Montrucchio; G Emanuelli; G Camussi
Journal:  J Mol Cell Cardiol       Date:  1992-02       Impact factor: 5.000

Review 7.  The role of the neutrophil and free radicals in ischemic myocardial injury.

Authors:  B R Lucchesi; S W Werns; J C Fantone
Journal:  J Mol Cell Cardiol       Date:  1989-12       Impact factor: 5.000

8.  The relationship between neutrophils and increased microvascular permeability in a model of myocardial ischaemia and reperfusion in the rabbit.

Authors:  F M Williams; P D Collins; M Tannière-Zeller; T J Williams
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

9.  Production and biologic interactions of prostacyclin and platelet-activating factor in acute myocardial ischemia in the perfused rabbit heart.

Authors:  F Berti; F Magni; G Rossoni; L De Angelis; G Galli
Journal:  J Cardiovasc Pharmacol       Date:  1990-11       Impact factor: 3.105

10.  Protection by superoxide dismutase from myocardial dysfunction and attenuation of vasodilator reserve after coronary occlusion and reperfusion in dog.

Authors:  J L Mehta; W W Nichols; W H Donnelly; D L Lawson; L Thompson; M ter Riet; T G Saldeen
Journal:  Circ Res       Date:  1989-11       Impact factor: 17.367

View more
  2 in total

Review 1.  Platelet activating factor in heart failure: potential role in disease progression and novel target for therapy.

Authors:  Paraskevi Detopoulou; Tzortzis Nomikos; Elizabeth Fragopoulou; Christina Chrysohoou; Smaragdi Antonopoulou
Journal:  Curr Heart Fail Rep       Date:  2013-06

Review 2.  Neutrophils: Beneficial and Harmful Cells in Septic Arthritis.

Authors:  Daiane Boff; Helena Crijns; Mauro M Teixeira; Flavio A Amaral; Paul Proost
Journal:  Int J Mol Sci       Date:  2018-02-05       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.